Daratumumab is a human monoclonal antibody targeting CD38, an antigen uniformly expressed by plasma cells in multiple myeloma and light-chain amyloidosis (AL).
Cat.No
A007
Name
Daratumumab
Chemical Properties
CAS
945721-28-8
Synonyms
Daratumumab;Darzalex;HuMax-CD 38;Daratumumab - 20mg/ml in water;Daratumumab 21.7mg/ml;Daratumumab USP/EP/BP;Research Grade Daratumumab(DHD80801);Anti-Human CD38, Human Antibody,myeloma,inhibit,tumor,antibody,cell,adhesion,cytotoxicity,Inhibitor,Daratumumab
pH value
Corresponds to reference standard： PASS
Non-reduced CE-SDS
99.1%
SEC-HPLC
99.6%
Isoelectric Point
Corresponds to reference standard:PASS
Bacterial Endotoxins Test
＜1 EU/ml
Residual Proteins of Host Cell
Exogenous Residual DNA
＜1 pg/mg
Residual protein A
＜1 ng/mg
Biological Activity
Compared with standard, the range of biological activity is 103%
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard:PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
